Russian mRNA cancer vaccine will cost 300 thousand rubles per patient
19 December 2024
Andrey Kaprin, Chief Oncologist of Russia’s Health Ministry, discussed a personalized mRNA cancer vaccine in a radio interview. The drug will be tailored for individual patients, costing the state 300,000 rubles per case.
18 medical organizations have received the right to manufacture and use biotechnological drugs
18 December 2024
Russian Prime Minister Mikhail Mishustin signed a document outlining which medical institutions can produce and use biotechnological drugs (BTLP). These are personalized drugs designed based on each patient’s genetic traits, reflecting a modern approach to gene and cell therapy.
The Ministry of Finance may expand the possibilities for offset contracts
18 December 2024
Deputy Minister of Finance of Russia, Alexey Lavrov, discussed upcoming changes in the import substitution of medicines and medical products. In particular, according to him, it is planned to expand the opportunities for offset contracts. For the first time, the option for multilateral offsets will be introduced, allowing multiple budgetary institutions to participate in a single offset contract.
17 December 2024
In light of recent reports highlighting a shortage of saline in medical facilities and pharmacies, the Russian Ministry of Industry and Trade has announced plans to boost sodium chloride production by domestic manufacturers to ensure that current market demands are fully satisfied.
Neonatal screening program to expand in 2025
17 December 2024
Currently, the expanded neonatal screening program covers more than 40 different pathologies, and from 2025 it will be supplemented with two more tests – for biotinidase deficiency and aromatic amino acid decarboxylase. In a forward-looking announcement made by Sergei Voronin, the head of the Bochkov Medical Genetics Research Center, during a meeting of the Federation Council, it was revealed that the future will see the integration of diagnostics for Duchenne muscular dystrophy.
The State Duma may oblige marketplaces to guarantee the quality of dietary supplements
16 December 2024
Dmitry Gusev, a deputy from Krasnodar Krai and the first deputy head of the “A Just Russia – For Truth” faction, has introduced a bill to parliament. This legislation mandates that online platforms verify information regarding dietary supplements before they can publish advertisements for their sale.
The Center for Microfluidic Technologies has opened in Moscow
16 December 2024
The Titan Group of Companies has launched a state-of-the-art Microfluidic Technology Center in Moscow, dedicated to producing advanced equipment for pharmaceuticals, cosmetics, agrochemical products, and petrochemicals. The Russian Ministry of Industry and Trade plans to provide Titan with a list of about 700 in-demand chemicals to determine the most suitable products for the use of microfluidic technologies.
Industry M&A volume declined 8% this year compared to '23: PwC
13 December 2024
Though M&A deal value and volume both declined in biopharma in 2024 compared to the year prior, PwC analysts still believe 2025 will be an active year for the sector.
The Russian Ministry of Health has created a Code of Ethics for AI in healthcare
13 December 2024
The Russian Ministry of Health has introduced a new Code of Ethics for AI use in healthcare. The document was developed with the participation of leading freelance specialists and experts, and was also agreed upon by the interdepartmental working group on AI in medicine, the press service of the department reported.
New Drug Shortages Monitoring Platform in Europe
12 December 2024
The European Medicines Agency (EMA) reported on Nov. 28, 2024 that the European Shortages Monitoring Platform (ESMP) is now live with core functionalities. ESMP enables marketing authorization holders (MAHs) to submit data to report shortages of centrally authorized medicines in the EuThe European Medicines Agency (EMA) reported on Nov. 28, 2024 that the European Shortages Monitoring Platform (ESMP) is now live with core functionalities. ESMP enables marketing authorization holders (MAHs) to submit data to report shortages of centrally authorized medicines in the European Union on a routine basis. Use of ESMP will become mandatory on Feb. 2, 2025, per Regulation 2022/123, which facilitates the exchange of information to prevent drug shortages in the EU.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
Enhancing spectroscopy analysis with machine learning
03 February 2025
The production of new Russian “super antibiotic” to begin in Novosibirsk
03 February 2025
A Russian company has started producing 4 veterinary vaccines
31 January 2025
The government held its first meeting on the “New technologies for preserving health” project
31 January 2025